Follow us on social

Shutterstock_1854498166-scaled

Biden takes a vital step on vaccine patents — but more action is needed

U.S. support for a patent waiver must be coupled with technology transfers, information sharing, and a coordinated global effort to distribute vaccines.

North America

The Biden administration’s announcement that it will support a WTO patent waiver for COVID-19 vaccines is a welcome step towards ending the global pandemic — but it must be followed by coordinated efforts to boost vaccine production through technology transfer, information sharing, and increased financing to have its promised effect.

The move is a heel-turn for the administration, which in March helped block a proposal led by India and South Africa to waive patents for Covid vaccines, treatments, and vital medical supplies in order to enable the production of affordable generics, particularly in the developing world.

This reversal, announced by U.S. Trade Representative Katherine Tai, comes after months of pressure from activists and public health experts around the globe.

U.S. support does not itself guarantee passage of a patent waiver, as the United States was previously joined in blocking the measure by the United Kingdom, the European Union, and a handful of other countries. It does, however, make it vastly more likely that remaining holdouts will shift their positions. (At this time, New Zealand has already suggested it will move to support the waiver).

While the administration’s announcement is undoubtedly good news, crucial questions remain. Notably, Tai’s statement does not say that the U.S. will support the specific proposal put forward by India and South Africa. This suggests that the United States may advocate for a modified or narrower plan in WTO negotiations. Tai’s announcement states only that the U.S. will support a waiver for vaccines, not for treatments and medical supplies as included in the earlier proposal. To maximize the benefits of a waiver, the Biden administration must be pushed to support the broadest possible proposal, ideally including COVID treatments and medical supplies.

Most importantly, the waiver will require follow-on action in the form of technology transfer and information sharing. While patents are a primary barrier to broader vaccine production, new manufacturers will also need access to key technologies and production information. 

The Biden administration should begin working now to facilitate technology transfer through the World Health Organization’s COVID-19 Technology Access Pool and to share manufacturing information held by Pfizer, Moderna, and others. It should also come up with a plan to finance scaled-up production and distribution of vaccines worldwide.

The administration cannot hesitate in taking these next steps. Its embrace of a patent waiver offers an unprecedented opportunity to bring a more swift end to the pandemic — and with cases surging in devastating outbreaks around the world, there is no time to spare.


(shutterstock.com)
North America
general Michael Kurilla Israel
Top photo credit: General Michael “Erik” Kurilla, commander of U.S. Central Command, visited Israel in July 2022 to meet with Israeli Defense Force (IDF) leadership, to include the IDF Chief of Staff, Lt General Aviv Kohavi. (U.S. Central Command public affairs)

Is Israel's favorite US general helping to push us into war?

Middle East

Did the Israelis strike Iran when it did because Michael Kurilla is still commander of U.S. Central Command and a “window” for a prospective joint operation with the U.S. might be closing?

Some are speculating that because Kurilla is expected to retire from the military this summer that the Israelis saw their chance. The Army general, 59, has been widely reported to be on one side of a split in the Pentagon over whether the U.S. should support and even be part of Israeli strikes against Iran’s nuclear program.

keep readingShow less
Baqubah, Iraq
Top image credit: Baqubah, Iraq, March 30, 2007 (Stacy L. Pearsall USAF photo)

Welcome to Iraq War 2.0

Middle East

Like all things in the Middle East, the U.S.–Israeli war on Iran can seem complicated. It’s not. The unprovoked Israeli attack on Iran is the 2003 Iraq War 2.0, except it has the potential to be far, far more catastrophic than the absolute catastrophe that was Iraq.

Like President George W. Bush’s 2003 war on Iraq, the war on Iran is an unprovoked, illegal, offensive, unilateral war of aggression, potentially aimed at regime change, and sold to the public based on lies about nonexistent weapons of mass destruction.

keep readingShow less
Soldiers Mali Africa
Top photo credit: Soldiers in Ansongo, Mali (Fred Marie/Shutterstock)

Wagner mercenaries declare 'mission accomplished' in Mali

Africa

On June 6, a Wagner-affiliated Telegram channel announced the Russian private military company’s (PMC) withdrawal from Mali, declaring “mission accomplished.”

After continuing operations in Mali nearly two years after the deaths of its founders, Yevgeny Prigozhin and Dmitry Utkin, the Russian state has finally subsumed Wagner’s structures under the Russian Ministry of Defense-subordinate, Africa Corps.

keep readingShow less

LATEST

QIOSK

Newsletter

Subscribe now to our weekly round-up and don't miss a beat with your favorite RS contributors and reporters, as well as staff analysis, opinion, and news promoting a positive, non-partisan vision of U.S. foreign policy.